Kepler Capital Remains a Buy on British American Tobacco (BATS)
Kepler Capital analyst Emanuele Sartori maintained a Buy rating on British American Tobacco on February 5 and set a price target of p4,900.00. The company’s shares closed yesterday at p4,555.00.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Sartori is ranked #8901 out of 11984 analysts.
Currently, the analyst consensus on British American Tobacco is a Moderate Buy with an average price target of p4,525.00, which is a -0.66% downside from current levels. In a report released on February 5, Barclays also maintained a Buy rating on the stock with a £49.00 price target.
Based on British American Tobacco’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of p12.07 billion and a net profit of p4.49 billion. In comparison, last year the company earned a revenue of p12.34 billion and had a net profit of p4.49 billion
Based on the recent corporate insider activity of 97 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of BATS in relation to earlier this year.
Read More on GB:BATS:
Disclaimer & DisclosureReport an Issue
- BAT Executives Reinvest Dividends Into Company Shares Under Incentive Plan
- BAT Executives Acquire Shares Through Dividend Reinvestment Plan
- BAT CEO Receives Dividend-Linked Share Award Under Deferred Bonus Scheme
- BAT Executives Add Shares Through HMRC-Approved Incentive Plan
- British American Tobacco Cancels New Tranche of Shares in Ongoing Buyback
